Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2010-07-22The Effect of Cigarette Holders, Plastic Menthol Cigarettes, and Cognitive Behavioral Therapy for Smoking Reduction Among Schizophrenia Inpatients: A Comparative Study
-
CLINICAL_TRIALS study record update · 2010-07-22Motivational Interviewing and Interaction Skills Training for Carers to Change Cannabis Use in Young Adults With Recent-onset Schizophrenia: Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2010-07-20A 16-Week, Multicenter, Randomized, Open-label Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2010-07-14Open Extension Study Evaluating the Safety and Tolerability of Oral Ziprasidone in the Treatment of Subjects Who Have Successfully Completed a Previous Ziprasidone Study
-
CLINICAL_TRIALS study record update · 2010-07-07Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2010-07-07A MULTI-CENTER, NON-INVASIVE OBSERVATIONAL STUDY OF METABOLIC SYNDROME PARAMETERS IN SCHIZOPHRENIC PATIENTS USING ATYPICAL ANTIPSYCHOTICS
-
CLINICAL_TRIALS study record update · 2010-07-05A Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the Safety and Efficacy of Asenapine With Olanzapine in Subjects Who Completed Protocol A7501013
-
CLINICAL_TRIALS study record update · 2010-06-30A Phase IIa, Double-blind, Double-Dummy, Placebo-controlled, Active-controlled, Randomized, Parallel-Group Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of AZD8529 in Adult Schizophrenia Patients
-
CLINICAL_TRIALS study record update · 2010-06-29A Six-Week, Randomized, Double-Blind, Parallel Group Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 Compared To Risperidone
-
CLINICAL_TRIALS study record update · 2010-06-29A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study to Determine the Efficacy, Tolerability and Safety of Low and High Non-overlapping Dose Ranges of BL-1020 Compared to Placebo and Risperidone
-
CLINICAL_TRIALS study record update · 2010-06-29Comparison Efficacy of Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients: Double-blind Placebo Controlled Study
-
CLINICAL_TRIALS study record update · 2010-06-28Attention and Grouping of Visual Information: What is Disturbed in Patients With Schizophrenia?
-
CLINICAL_TRIALS study record update · 2010-06-28Microglia Activation in Schizophrenia: a Pilot Study
-
CLINICAL_TRIALS study record update · 2010-06-23ClinicalTrials.gov study NCT01149577
-
CLINICAL_TRIALS study record update · 2010-06-15A 6-Week, Multicenter, Rater-blind, Randomized, Risperidone-controlled Study to Evaluate the Efficacy and Safety of Seroquel (Quetiapine Fumarate) in the Treatment of Chinese Han Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-06-09QUALITY: A Non-interventional Study Evaluating Quality Of Life in Schizophrenic Patients Treated With Atypical Antipsychotics, in the Ambulatory Setting. A 9-month, Observational, Multicentric Prospective Study.
-
CLINICAL_TRIALS study record update · 2010-06-09A Randomized, Multicenter, Double-Blind, Weight-Based, Fixed-Dose, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Extended Release Paliperidone for the Treatment of Schizophrenia in Adolescent Subjects, 12 to 17 Years of Age
-
CLINICAL_TRIALS study record update · 2010-05-28A Randomized, Placebo-Controlled, Double-Blind Trial of Asenapine in the Prevention of Relapse After Long-Term Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-05-25Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
-
CLINICAL_TRIALS study record update · 2010-05-24A Double-blind, Placebo-controlled, Randomized Study Evaluating the Effect of Paliperidone ER Compared With Placebo on Sleep Architecture in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-05-1926-Week Open-Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Adolescent Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-05-18Promoting Adherence to Treatment in Schizophrenia
-
CLINICAL_TRIALS study record update · 2010-05-17Treatment of Schizophrenic Patients With Geodon; Capsules/Oral Suspension/Solution for Injection (Ziprasidone)
-
CLINICAL_TRIALS study record update · 2010-05-14Clozapine and Olanzapine in the Treatment of Violence in Schizophrenic Patients
-
CLINICAL_TRIALS study record update · 2010-05-07A Phase I, Open-Label,Positron Emission Tomography (PET) Study Healthy Subjects Following a Single Oral Dose of OPC-34712